Clinical Trial Update: Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluated methylprednisolone's effects on immune signaling in hip arthroplasty patients with osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Osteoarthrosis | Phase 2, Phase 3 | Status: COMPLETED